{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:33:48Z","timestamp":1792730028963,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T00:00:00Z","timestamp":1313020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00262-011-1087-2","type":"journal-article","created":{"date-parts":[[2011,8,10]],"date-time":"2011-08-10T11:44:31Z","timestamp":1312976671000},"page":"31-40","source":"Crossref","is-referenced-by-count":48,"title":["HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response"],"prefix":"10.1007","volume":"61","author":[{"given":"Gaia","family":"Codolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Fassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Munari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piefrancesco","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Rugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Milco","family":"D\u2019Elios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"de Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,11]]},"reference":[{"issue":"5","key":"1087_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A et al (2010) Cancer statistics. CA Cancer J Clin 60(5):277\u2013300","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1087_CR2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/87.3.175","volume":"87","author":"SS Devesa","year":"1995","unstructured":"Devesa SS et al (1995) Recent cancer trends in the united states. J Natl Cancer Inst 87(3):175\u2013182","journal-title":"J Natl Cancer Inst"},{"issue":"3 Suppl","key":"1087_CR3","first-page":"5","volume":"31","author":"MS Soloway","year":"1988","unstructured":"Soloway MS (1988) Introduction and overview of intravesical therapy for superficial bladder cancer. Urology 31(3 Suppl):5\u201316","journal-title":"Urology"},{"issue":"6","key":"1087_CR4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0090-4295(94)90134-1","volume":"43","author":"Y Hasui","year":"1994","unstructured":"Hasui Y et al (1994) Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer. Urology 43(6):782\u2013786","journal-title":"Urology"},{"issue":"1","key":"1087_CR5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-5347(05)65469-9","volume":"167","author":"F Saint","year":"2002","unstructured":"Saint F et al (2002) Prognostic value of a T helper 1 urinary cytokine response after intravesical bacillus Calmette-Guerin treatment for superficial bladder cancer. J Urol 167(1):364\u2013367","journal-title":"J Urol"},{"issue":"1","key":"1087_CR6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-5347(05)64044-X","volume":"169","author":"O Shahin","year":"2003","unstructured":"Shahin O et al (2003) A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol 169(1):96\u2013100 discussion 100","journal-title":"J Urol"},{"issue":"3","key":"1087_CR7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0094-0143(21)00423-7","volume":"19","author":"DL Lamm","year":"1992","unstructured":"Lamm DL (1992) Complications of bacillus Calmette-Guerin immunotherapy. Urol Clin North Am 19(3):565\u2013572","journal-title":"Urol Clin North Am"},{"issue":"6","key":"1087_CR8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0090-4295(91)80166-5","volume":"38","author":"R Jager De","year":"1991","unstructured":"De Jager R et al (1991) Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trials. Urology 38(6):507\u2013513","journal-title":"Urology"},{"issue":"2","key":"1087_CR9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1359-6101(01)00032-6","volume":"13","author":"MP Colombo","year":"2002","unstructured":"Colombo MP, Trinchieri G (2002) Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev 13(2):155\u2013168","journal-title":"Cytokine Growth Factor Rev"},{"key":"1087_CR10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1600-065X.2008.00604.x","volume":"222","author":"MA Cheever","year":"2008","unstructured":"Cheever MA (2008) Twelve immunotherapy drugs that could cure cancers. Immunol Rev 222:357\u2013368","journal-title":"Immunol Rev"},{"issue":"7","key":"1087_CR11","first-page":"2541","volume":"90","author":"JP Leonard","year":"1997","unstructured":"Leonard JP et al (1997) Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 90(7):2541\u20132548","journal-title":"Blood"},{"issue":"15","key":"1087_CR12","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1158\/0008-5472.CAN-09-1114","volume":"69","author":"DA Zaharoff","year":"2009","unstructured":"Zaharoff DA et al (2009) Intravesical immunotherapy of superficial bladder cancer with chitosan\/interleukin-12. Cancer Res 69(15):6192\u20136199","journal-title":"Cancer Res"},{"issue":"4","key":"1087_CR13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1172\/JCI27177","volume":"116","author":"A Amedei","year":"2006","unstructured":"Amedei A et al (2006) The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 116(4):1092\u20131101","journal-title":"J Clin Invest"},{"key":"1087_CR14","doi-asserted-by":"crossref","unstructured":"de Bernard M, D\u2019Elios MM (2009) The immune modulating activity of the Helicobacter pylori HP-NAP: Friend or foe? Toxicon 56:1186\u20131192","DOI":"10.1016\/j.toxicon.2009.09.020"},{"issue":"11","key":"1087_CR15","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/j.1462-5822.2008.01217.x","volume":"10","author":"G Codolo","year":"2008","unstructured":"Codolo G et al (2008) The neutrophil-activating protein of Helicobacter pylori down-modulates Th2 inflammation in ovalbumin-induced allergic asthma. Cell Microbiol 10(11):2355\u20132363","journal-title":"Cell Microbiol"},{"issue":"1","key":"1087_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1172\/JCI200110128","volume":"108","author":"JM Wigginton","year":"2001","unstructured":"Wigginton JM et al (2001) IFN-gamma and Fas\/FasL are required for the antitumor and antiangiogenic effects of IL-12\/pulse IL-2 therapy. J Clin Invest 108(1):51\u201362","journal-title":"J Clin Invest"},{"issue":"4","key":"1087_CR17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1074-7613(00)80119-3","volume":"11","author":"O Takeuchi","year":"1999","unstructured":"Takeuchi O et al (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11(4):443\u2013451","journal-title":"Immunity"},{"issue":"2","key":"1087_CR18","first-page":"401","volume":"143","author":"N Weidner","year":"1993","unstructured":"Weidner N et al (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143(2):401\u2013409","journal-title":"Am J Pathol"},{"issue":"12","key":"1087_CR19","first-page":"2834","volume":"59","author":"JH Gunther","year":"1999","unstructured":"Gunther JH et al (1999) Optimizing syngeneic orthotopic murine bladder cancer (MB49). Cancer Res 59(12):2834\u20132837","journal-title":"Cancer Res"},{"issue":"2","key":"1087_CR20","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4049\/jimmunol.158.2.962","volume":"158","author":"MM D\u2019Elios","year":"1997","unstructured":"D\u2019Elios MM et al (1997) T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 158(2):962\u2013967","journal-title":"J Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-011-1087-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-011-1087-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-011-1087-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T17:19:14Z","timestamp":1686244754000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-011-1087-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,11]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1087"],"URL":"https:\/\/doi.org\/10.1007\/s00262-011-1087-2","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,11]]}}}